Austin E H, Edmonds H L, Auden S M, Seremet V, Niznik G, Sehic A, Sowell M K, Cheppo C D, Corlett K M
Department of Surgery, University of Louisville School of Medicine, Ky., USA.
J Thorac Cardiovasc Surg. 1997 Nov;114(5):707-15, 717; discussion 715-6. doi: 10.1016/S0022-5223(97)70074-6.
Pediatric patients undergoing repair of congenital cardiac abnormalities have a significant risk of an adverse neurologic event. Therefore this retrospective cohort study examined the potential benefit of interventions based on intraoperative neurophysiologic monitoring in decreasing both postoperative neurologic sequelae and length of hospital stay as a cost proxy.
With informed parental consent approved by the institutional review board, electroencephalography, transcranial Doppler ultrasonic measurement of middle cerebral artery blood flow velocity, and transcranial near-infrared cerebral oximetry were monitored in 250 patients. An interventional algorithm was used to detect and correct specific deficiencies in cerebral perfusion or oxygenation or to increase cerebral tolerance to ischemia or hypoxia.
Noteworthy changes in brain perfusion or metabolism were observed in 176 of 250 (70%) patients. Intervention that altered patient management was initially deemed appropriate in 130 of 176 (74%) patients with neurophysiologic changes. Obvious neurologic sequelae (i.e., seizure, movement, vision or speech disorder) occurred in five of 74 (7%) patients without noteworthy change, seven of 130 (6%) patients with intervention, and 12 of 46 (26%) patients without intervention (p = 0.001). Survivors' median length of stay was 6 days in the no-change and intervention groups but 9 days in the no-intervention group. In addition, the percentage of patients in the no-intervention group discharged from the hospital within 1 week (32%) was significantly less than that in either the intervention (51%, p = 0.05) or no-change (58%, p = 0.01) groups. On the basis of an estimated hospital neurologic complication cost of $1500 per day, break-even analysis justified a hospital expenditure for neurophysiologic monitoring of $2142 per case.
Interventions based on neurophysiologic monitoring appear to decrease the incidence of postoperative neurologic sequelae and reduce the length of stay. Inasmuch as the break-even cost for neurophysiologic monitoring is more than four times the actual average charge, both patients and hospital may profit from this service. Because this study was not a truly randomized clinical trial, unintentional statistical bias may have occurred and caution is urged in interpreting the magnitude of apparent intergroup outcome differences.
接受先天性心脏畸形修复手术的儿科患者发生不良神经事件的风险很高。因此,这项回顾性队列研究探讨了基于术中神经生理监测的干预措施在降低术后神经后遗症和缩短住院时间(作为成本替代指标)方面的潜在益处。
在获得机构审查委员会批准的家长知情同意后,对250例患者进行了脑电图、经颅多普勒超声测量大脑中动脉血流速度以及经颅近红外脑氧饱和度监测。采用一种干预算法来检测和纠正脑灌注或氧合方面的特定缺陷,或提高大脑对缺血或缺氧的耐受性。
250例患者中有176例(70%)观察到脑灌注或代谢有显著变化。在176例有神经生理变化的患者中,最初认为有130例(74%)患者适合改变患者管理的干预措施。在74例无显著变化的患者中有5例(7%)、130例接受干预的患者中有7例(6%)以及46例未接受干预的患者中有12例(26%)出现明显的神经后遗症(即癫痫、运动、视力或言语障碍)(p = 0.001)。在无变化组和干预组中,幸存者的中位住院时间为6天,而在未干预组中为9天。此外,未干预组中在1周内出院的患者百分比(32%)显著低于干预组(51%,p = 0.05)或无变化组(58%,p = 0.01)。根据估计的医院神经并发症成本为每天1500美元,盈亏平衡分析表明每例患者进行神经生理监测的医院支出为2142美元是合理的。
基于神经生理监测的干预措施似乎可降低术后神经后遗症的发生率并缩短住院时间。鉴于神经生理监测的盈亏平衡成本是实际平均收费的四倍多,患者和医院都可能从这项服务中受益。由于这项研究并非真正的随机临床试验,可能发生了无意的统计偏差,因此在解释组间明显的结果差异程度时需谨慎。